HK1037974A1 - Pharmaceutical formulations for aerosols with two or more active substances. - Google Patents

Pharmaceutical formulations for aerosols with two or more active substances.

Info

Publication number
HK1037974A1
HK1037974A1 HK01108873A HK01108873A HK1037974A1 HK 1037974 A1 HK1037974 A1 HK 1037974A1 HK 01108873 A HK01108873 A HK 01108873A HK 01108873 A HK01108873 A HK 01108873A HK 1037974 A1 HK1037974 A1 HK 1037974A1
Authority
HK
Hong Kong
Prior art keywords
aerosols
active substances
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
HK01108873A
Other languages
English (en)
Inventor
Daniel P Mcnamara
George A Destefano
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1037974(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/de
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HK1037974A1 publication Critical patent/HK1037974A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK01108873A 1998-06-18 2001-12-19 Pharmaceutical formulations for aerosols with two or more active substances. HK1037974A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (de) 1998-06-18 1998-06-18 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
DE1998142963 DE19842963A1 (de) 1998-09-19 1998-09-19 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
PCT/US1999/012785 WO1999065464A1 (en) 1998-06-18 1999-06-08 Pharmaceutical formulations for aerosols with two or more active substances

Publications (1)

Publication Number Publication Date
HK1037974A1 true HK1037974A1 (en) 2002-03-01

Family

ID=26046888

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108873A HK1037974A1 (en) 1998-06-18 2001-12-19 Pharmaceutical formulations for aerosols with two or more active substances.

Country Status (33)

Country Link
EP (1) EP1087750B1 (id)
JP (1) JP2003522102A (id)
KR (1) KR100600423B1 (id)
CN (1) CN1161104C (id)
AR (1) AR019690A1 (id)
AT (1) ATE253896T1 (id)
AU (1) AU759222B2 (id)
BG (1) BG65252B1 (id)
BR (1) BR9911351A (id)
CA (1) CA2335065C (id)
CO (1) CO5070580A1 (id)
CZ (1) CZ300910B6 (id)
DE (1) DE69912781T2 (id)
DK (1) DK1087750T3 (id)
EE (1) EE04450B1 (id)
ES (1) ES2211108T3 (id)
HK (1) HK1037974A1 (id)
HR (1) HRP20000867B1 (id)
HU (1) HU229064B1 (id)
ID (1) ID27554A (id)
IL (2) IL140353A0 (id)
ME (1) ME00838B (id)
MY (1) MY121073A (id)
NO (1) NO329416B1 (id)
NZ (1) NZ509418A (id)
PL (1) PL193695B1 (id)
PT (1) PT1087750E (id)
RS (1) RS49977B (id)
RU (1) RU2218152C2 (id)
SK (1) SK284756B6 (id)
TR (1) TR200003721T2 (id)
TW (1) TW528606B (id)
WO (1) WO1999065464A1 (id)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
FR2798290B1 (fr) 1999-09-11 2003-09-12 Glaxo Group Ltd Formulation pharmaceutique de propionate de fluticasone
ATE286716T1 (de) * 1999-11-23 2005-01-15 Glaxo Group Ltd Pharmazeutische formulierungen enthaltend salmeterol
DE60019167T2 (de) * 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
BRPI0212586B8 (pt) 2001-09-18 2021-05-25 Nycomed Danmark Aps composição na forma de uma solução aquosa, e, uso da mesma
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2408500B1 (en) 2009-03-17 2015-04-29 Boehringer Ingelheim International GmbH Dispensing device, and storage device for dispensing a formulation
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
NZ599295A (en) 2009-11-25 2014-06-27 Boehringer Ingelheim Int Nebulizer
EP3020393B1 (en) 2009-12-16 2020-10-07 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
US10716906B2 (en) 2014-05-07 2020-07-21 Boehringer Ingelheim International Gmbh Nebulizer and container
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
PL177078B1 (pl) * 1992-12-09 1999-09-30 Boehringer Ingelheim Pharma Preparaty roztworów aerozolowych
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation

Also Published As

Publication number Publication date
TR200003721T2 (tr) 2001-06-21
CA2335065A1 (en) 1999-12-23
SK19392000A3 (sk) 2001-07-10
KR20010072621A (ko) 2001-07-31
CN1307470A (zh) 2001-08-08
CZ300910B6 (cs) 2009-09-09
JP2003522102A (ja) 2003-07-22
EE04450B1 (et) 2005-04-15
DE69912781D1 (de) 2003-12-18
HUP0104734A3 (en) 2003-05-28
HUP0104734A2 (hu) 2002-05-29
PL345685A1 (en) 2002-01-02
TW528606B (en) 2003-04-21
HRP20000867B1 (en) 2010-10-31
AU4552199A (en) 2000-01-05
RS49977B (sr) 2008-09-29
IL140353A0 (en) 2002-02-10
EP1087750B1 (en) 2003-11-12
DE69912781T2 (de) 2004-10-21
CZ20004750A3 (en) 2001-05-16
PL193695B1 (pl) 2007-03-30
AR019690A1 (es) 2002-03-13
ATE253896T1 (de) 2003-11-15
BG65252B1 (bg) 2007-10-31
KR100600423B1 (ko) 2006-07-13
YU80000A (sh) 2003-04-30
AU759222B2 (en) 2003-04-10
ES2211108T3 (es) 2004-07-01
NO329416B1 (no) 2010-10-18
NO20006318D0 (no) 2000-12-12
BG105033A (en) 2001-09-28
CO5070580A1 (es) 2001-08-28
RU2218152C2 (ru) 2003-12-10
CN1161104C (zh) 2004-08-11
MY121073A (en) 2005-12-30
BR9911351A (pt) 2001-03-13
EP1087750A1 (en) 2001-04-04
CA2335065C (en) 2008-06-03
HU229064B1 (en) 2013-07-29
NO20006318L (no) 2001-01-30
NZ509418A (en) 2003-06-30
HRP20000867A2 (en) 2001-10-31
ID27554A (id) 2001-04-12
DK1087750T3 (da) 2004-01-26
SK284756B6 (sk) 2005-11-03
ME00838B (me) 2008-09-29
EE200000759A (et) 2002-04-15
PT1087750E (pt) 2004-02-27
WO1999065464A1 (en) 1999-12-23
IL140353A (en) 2006-09-05

Similar Documents

Publication Publication Date Title
HK1037974A1 (en) Pharmaceutical formulations for aerosols with two or more active substances.
ZA993338B (en) Pharmaceutical formulations.
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
ZA200200743B (en) Preserved pharmaceutical formulations.
HK1022271A1 (en) Pharmaceutical aerosol composition.
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HK1027957A1 (en) Pharmaceutical composition.
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
ZA200005510B (en) Pharmaceutical composition.
ZA989680B (en) Pharmaceutical composition.
HK1040488A1 (en) Pharmaceutical formulations.
ZA987392B (en) Pharmaceutical composition.
HK1044117A1 (en) Pharmaceutical composition.
GB9818927D0 (en) Pharmaceutical formulation
ZA99890B (en) Pharmaceutical compositions.
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
GB9822333D0 (en) Pharmaceutical formulation
ZA994697B (en) Pharmaceutical formulation.
GB9817470D0 (en) Pharmaceutical formulation
SI1087750T1 (en) Pharmaceutical formulations for aerosols with two or more active substances
ZA99918B (en) Pharmaceutical formulation.
ZA200005761B (en) Pharmaceutical aerosol formulation.
ZA997202B (en) Pharmaceutical composition.
HK1051784A1 (en) Pharmaceutical composition.
ZA997229B (en) Medicinal formulation.